95 filings
25-NSE
The Nasdaq Stock Market LLC
7 Mar 24
Exchange delisting
9:03am
15-12G
AMAM
Ambrx Biopharma Inc.
23 Oct 23
Securities registration termination
5:19pm
S-8 POS
Ambrx Biopharma Inc.
12 Oct 23
Registration of securities for employees (post-effective amendment)
4:20pm
S-8 POS
Ambrx Biopharma Inc.
12 Oct 23
Registration of securities for employees (post-effective amendment)
4:15pm
S-8 POS
Ambrx Biopharma Inc.
12 Oct 23
Registration of securities for employees (post-effective amendment)
4:10pm
S-8 POS
ausuer5 828s
12 Oct 23
Registration of securities for employees (post-effective amendment)
4:05pm
25-NSE
0qguii9d3r
12 Oct 23
Exchange delisting
3:41pm
8-K
0ntuij
12 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:04am
8-K
vh6d20au
10 Oct 23
Submission of Matters to a Vote of Security Holders
4:49pm
8-K
kfdng4wi4gz75gnhjh
6 Oct 23
Departure of Directors or Certain Officers
4:07pm
8-K
ct4588m
22 Sep 23
Termination of a Material Definitive Agreement
5:36pm
DEFM14A
3z8hes92n bp
15 Sep 23
Proxy related to merger
4:27pm
8-K
gnzcvto
15 Sep 23
Entry into a Material Definitive Agreement
4:24pm
8-K
kwxp3 8ddd
6 Sep 23
Departure of Directors or Certain Officers
4:05pm
8-K
ro7cng3 rjq3nxckipkv
25 Aug 23
Other Events
5:23pm
8-K
ic477obtdu0ubwb
28 Jun 23
Ambrx Announces Closing of $75 Million Market Priced Registered
4:06pm
8-K
2yimkuc21aa7a2zr3vu
8 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
eyy2g40ky4jx5x5d
25 May 23
Ambrx Announces $75 Million Market Priced Registered Offering
4:08pm
424B5
iv40 8yfgnn
25 May 23
Prospectus supplement for primary offering
4:07pm